Library — CHDR

Search

Filter

Complement Activation in Inflammatory Skin Diseases.

Giang J, Seelen MAJ, van Doorn MBA, Rissmann R, Prens EP, Damman J

Frontiers in immunology, 2018 Jul

View publication
Comprehensive, Multimodal Characterization of an Imiquimod-Induced Human Skin Inflammation Model for Drug Development.

van der Kolk T, Assil S, Rijneveld R, Klaassen ES, Feiss G, Florencia E, Prens EP, Burggraaf J, Moerland M, Rissmann R, van Doorn MBA

Clinical and translational science, 2018 Jul

View publication
Rifampin levels in daily practice: the accuracy of a single measurement.

Vanbrabant TJF, Dijkmans AC, den Hartigh J, Touw DJ, Arend SM

The Netherlands journal of medicine, 2018 Jul; 76(5):235-242

View publication
Subanesthetic Dose Ketamine in Posttraumatic Stress Disorder: A Role for Reconsolidation During Trauma-Focused Psychotherapy?

Veen C, Jacobs G, Philippens I, Vermetten E

Current topics in behavioral neurosciences, 2018 Jun

View publication
Mitochondrial function is impaired in the skeletal muscle of pre-frail elderly.

Andreux PA, van Diemen MPJ, Heezen MR, Auwerx J, Rinsch C, Jan Groeneveld G, Singh A

Scientific reports, 2018 Jun; 8(1):8548

View publication
GSH-PEGylated liposomal methylprednisolone in comparison to free methylprednisolone: slow release characteristics and prolonged lymphocyte depression in a first-in-human study.

Kanhai KMS, Zuiker RGJA, Stavrakaki I, Gladdines W, Gaillard PJ, Klaassen ES, Groeneveld GJ

British journal of clinical pharmacology, 2018 May

View publication
Futility of current urine salbutamol doping control.

Heuberger JAAC, van Dijkman SC, Cohen AF

British journal of clinical pharmacology, 2018 May

View publication
Commentary on the EMA Guideline on strategies to identify and mitigate risks for first-in-human and early clinical trials with investigational medicinal products (EMEA/CHMP/SWP/28367/07 Rev. 1.

van Gerven J, Bonelli M

British journal of clinical pharmacology, 2018 May

View publication
The identification of patients at high risk for recurrent disease after treatment for early-stage cervical cancer

van Meir H, du Burck IJ, de Kam ML, Welters MJP, van der Burg SH, Trimbos JBMZ, de Kroon CD, van Poelgeest MIE.

2018 May

View publication

«
1
2
...
36
37
38
39
40
41
42
...
98
99
»